Reinforcing effects of caffeine in humans
- PMID: 3392652
Reinforcing effects of caffeine in humans
Abstract
The reinforcing and subjective effects of caffeine were studied under double-blind conditions in 12 normal humans. After 2 forced exposure days on which subjects received color-coded capsules containing either caffeine (100, 200, 400 or 600 mg) or placebo, subjects had a choice day on which they chose which one of the two types of color-coded capsules would be ingested. Subjects were exposed to 10 experimentally independent choices (i.e., involving exposure and choice between novel color-coded capsule conditions) at each of several dose levels. All forced exposure and choice opportunities occurred when subjects were overnight abstinent from their normal dietary caffeine intake (mean, 116 mg/day). Significant caffeine positive reinforcement was demonstrated in 5 of 12 subjects at one or more doses. Percentage of selection of caffeine was inversely related to dose, with four subjects showing significant caffeine avoidance at 400 and/or 600 mg. Choice behavior was correlated positively with feelings of contentedness and was correlated negatively with prestudy trait anxiety scores and with ratings of capsule disliking. Compared to placebo, caffeine produced increases in subjective ratings indicating arousal while producing decreases in headache and "craving" for caffeine-containing foods, even at the lowest dose of 100 mg. At higher doses caffeine produced dysphoric anxiety-like subjective effects. Overall, this study provides the first demonstration in humans of the positive reinforcing effects of caffeine alone (i.e., in capsules) and documents individual differences among normal subjects in both caffeine positive reinforcement and caffeine avoidance.
Similar articles
-
Low-dose caffeine discrimination in humans.J Pharmacol Exp Ther. 1990 Mar;252(3):970-8. J Pharmacol Exp Ther. 1990. PMID: 2319479 Clinical Trial.
-
Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers.Psychopharmacology (Berl). 2003 Jan;165(3):280-90. doi: 10.1007/s00213-002-1262-4. Epub 2002 Nov 14. Psychopharmacology (Berl). 2003. PMID: 12434259 Clinical Trial.
-
Haloperidol reduces stimulant and reinforcing effects of ethanol in social drinkers.Alcohol Clin Exp Res. 2001 Oct;25(10):1448-56. Alcohol Clin Exp Res. 2001. PMID: 11696664 Clinical Trial.
-
Intravenous nicotine and caffeine: subjective and physiological effects in cocaine abusers.J Pharmacol Exp Ther. 2001 Feb;296(2):486-94. J Pharmacol Exp Ther. 2001. PMID: 11160635 Clinical Trial.
-
Caffeine as a model drug of dependence: recent developments in understanding caffeine withdrawal, the caffeine dependence syndrome, and caffeine negative reinforcement.Nihon Shinkei Seishin Yakurigaku Zasshi. 2000 Nov;20(5):223-31. Nihon Shinkei Seishin Yakurigaku Zasshi. 2000. PMID: 11326548 Review.
Cited by
-
Caffeine withdrawal, acute effects, tolerance, and absence of net beneficial effects of chronic administration: cerebral blood flow velocity, quantitative EEG, and subjective effects.Psychopharmacology (Berl). 2009 Jul;204(4):573-85. doi: 10.1007/s00213-009-1489-4. Epub 2009 Feb 25. Psychopharmacology (Berl). 2009. PMID: 19241060 Free PMC article. Clinical Trial.
-
A temporal and spatial scaling hypothesis for the behavioral effects of psychostimulants.Psychopharmacology (Berl). 1991;104(1):6-16. doi: 10.1007/BF02244547. Psychopharmacology (Berl). 1991. PMID: 1679242
-
The role of nicotine in tobacco use.Psychopharmacology (Berl). 1992;108(4):397-407. doi: 10.1007/BF02247412. Psychopharmacology (Berl). 1992. PMID: 1410152 Review.
-
Caffeine tolerance and choice in humans.Psychopharmacology (Berl). 1992;108(1-2):51-9. doi: 10.1007/BF02245285. Psychopharmacology (Berl). 1992. PMID: 1410146
-
Genetics of caffeine consumption and responses to caffeine.Psychopharmacology (Berl). 2010 Aug;211(3):245-57. doi: 10.1007/s00213-010-1900-1. Epub 2010 Jun 9. Psychopharmacology (Berl). 2010. PMID: 20532872 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical